Search

Your search keyword '"Charbit, Bruno"' showing total 139 results

Search Constraints

Start Over You searched for: Author "Charbit, Bruno" Remove constraint Author: "Charbit, Bruno"
139 results on '"Charbit, Bruno"'

Search Results

1. Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people

3. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

4. Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks

9. Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity

10. A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis

11. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients

13. Platelet activation in critically ill COVID-19 patients

14. Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people.

17. Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral and T-cell stimulation reveals new immune networks

18. Systemic immunosuppression depletes peripheral blood regulatory B cells in patients with immune thrombocytopenia.

19. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

20. Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses

22. Variability of Primary Sjögren's Syndrome Is Driven by Interferon α and Interferon α Blood Levels Are Associated With the Class II HLA–DQ Locus

23. Defective type I interferon immunity is associated with increasing COVID-19 severity

24. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

25. Additional file 2 of Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes

26. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway

28. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

29. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

30. Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection

31. Safety of sitagliptin in treatment of hepatocellular carcinoma in chronic liver disease patients

32. Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection

33. Additional file 1 of Platelet activation in critically ill COVID-19 patients

34. Additional file 2 of Platelet activation in critically ill COVID-19 patients

36. Immune profiling enables stratification of patients with active TB disease or M. tuberculosis infection

37. Antibody-coated microbiota in nasopharynx of healthy individuals and hypogammaglobulinemia patients

38. Associations between untargeted plasma metabolomic signatures and gut microbiota composition in the Milieu Intérieur population of healthy adults

39. Distinct systemic and mucosal immune responses to SARS-CoV-2

40. Early IFNβ Secretion Determines Variable Downstream IL-12p70 Responses Upon TLR4 Activation

41. A Monocyte/Dendritic Cell Molecular Signature of SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C) with Severe Myocarditis

42. Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses

43. Dysregulated primary hemostasis in critically ill COVID-19 patients

44. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

45. Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients

46. Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement—A new target for lupus treatment

47. Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacterium tuberculosis Infection.

48. Associations between untargeted plasma metabolomic signatures and gut microbiota composition in the Milieu Intérieur population of healthy adults.

49. Additional file 2: of Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines

50. Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children

Catalog

Books, media, physical & digital resources